| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.08 |